Fast food is one of the largest industries in the world. According to The Healthy Eating Guide, there are over 25,000 fast food chains in the United States only and Americans are spending over $140 billion on fast food every year. But an industry this big does not go by without leaving its mark, or what environmentalists are calling “footprints.” But what if that industry could “give back” by turning its leftover cooking oil into green biodiesel for your cars?
That is exactly what two Israeli scientists are trying to do. Dr. Sobhi Basheer and Dr. Ahmed Tafesh of TransBiodiesel, have developed a new process by which any oil, including leftovers of fast food joints, or “falafel stands,” as they say, can be turned into biodiesel, without requiring much energy in the process.
TransBiodiesel is a BIRD grantee.
December 28, 2011
Applicability of the model that successfully matched the US and Israeli firms for R&D projects to Turkey discussed.
ANKARA – TEPAV organized a meeting as a part of the Global Entrepreneurship Program (GEP)-Turkey that brought together representatives from institutions that support technology development and the innovation system in Turkey, to have a better understanding of the BIRD (Israel-U.S. Bi-national Industrial Research and Development Foundation) model.
The meeting hosted the director of the U.S. Business Development and BIRD Energy department of BIRD Foundation, Limor Nakar Vincent, who made a presentation about the mechanisms, structure and investments of the BIRD model
The Economic Policy Research Foundation of Turkey
December 20, 2011
CellEra, the leading developer of cost-effective Platinum Free Fuel Cell technology has announced today a $9.2M investment round led by Vodafone Ventures, the global venture capital arm of Vodafone Group, together with top-tier Israeli VC firm Carmel Ventures. The two have joined forces with the company’s largest shareholder Israel Cleantech Ventures, the leading venture capital fund focused on backing Israel’s emerging clean technology companies, as well as B-2-V Partners and private investors.
Cellera is a recipient of BIRD funding.
December 19, 2011
Healthline and Wolfram Alpha have both announced new features specifically related to comsumer health information. Healthline now offers a social search feature that taps into crowd sourced information on drug experiences while Wolfram Alpha taps into a rich compilation of clinical data.
Healthline Networks and First Life Research received a grant for their joint project from the BIRD Foundation.
Rob D. Young
December 16, 2011
Collaboration Expands Existing Relationship to Address Important Soybean Traits
DuPont and Evogene Ltd. today announced a multiyear collaboration to improve resistance to soybean rust, one of the most devastating fungal diseases in soybean.
Under the agreement, DuPont business Pioneer Hi-Bred and Evogene will collaborate to develop soybean varieties displaying in-plant resistance to rust.
Evogene is a recipient of BIRD funding
November 21, 2011
Israel should invest in PV research, ventures, and innovation in order to become one of the leaders in this industry.
The collapse of California solar panel manufacturer Solyndra Inc. sent shockwaves across the US and raised questions in Congress over government loans to the company. Two other solar energy companies have also gone bankrupt: Massachusetts-based Evergreen Solar Inc. and New York-based SpectraWatt Inc., and BP Solar has closed its operations in Maryland.
Dr. Eitan Yudilevich
Israel business news – www.globes-online.com
November 2, 2011
By making sense of billions of health related online discussions, Treato enables patients to understand the experiences of others and make better informed healthcare decisions.
First Life Research™ has created Treato™ – the most comprehensive searchable medical database, based solely on user generated content provided by patients across the U.S.
FLR received recognition for its novel technology by the Israel-US Binational Industrial Research and Development (BIRD) Foundation when awarded a grant for its joint project with Healthline Networks, Inc.
First Life Research™
September 26, 2011
In the middle of June, a day after we were informed that the market continues to grow impressively and the employment situation continues to improve, the unemployment rate in Israel reached about 6% – “among the lowest in the past 25 years” – a lunar eclipse occurred, which reminded us of what was occurring across the sea, in Israel’s undisputed friend – the United States of America.
Executive Director of the BIRD Foundation
Translated from: The Marker – July 05 2011
Click here to read the HEBREW version
The Israeli company expects clinical trials to position its tiny implant as the most advanced solution for people with damaged retinas.
Bio-Retina is activated by special eyeglasses, transforming light into an electrical impulse that stimulates the neurons to send images to the brain.
With investment money from its founding partners, and a grant from BIRD, the US-Israel Bilateral Research and Development Fund, Nano Retina plans to start clinical trials in 2013.
June 12, 2011
Nano Retina is developing a tiny bionic retinal implant designed to restore vision to tens of millions of people who have been blinded by retinal diseases, such as age-related macular degeneration (“AMD”).
Following a 30-minute, minimally invasive procedure requiring local anesthesia, sight will be returned to those receiving the implant which will allow them to read and watch television again
Nano Retina is an Israeli company established in 2009. It is a privately held joint venture between Rainbow Medical and Zyvex Labs.
Nano Retina has received an approval for a BIRD Foundation grant in December2009.
June 06, 2011
Regional Cooperation Can Minimize Oil Dependency
Dr. Eitan Yudilevich
Executive Director of the BIRD Foundation and the TRIDE Fund
Translated from The Marker- הארץ- 28-4-2011
Click here to read the Hebrew version
I was in Cairo on the Friday of Rage. When we landed back in Ben Gurion after four fascinating days in Cairo, I was received like a soldier returning from the front. Hugs and expressions of empathy for what I had gone through. Curiosity as to how I had ever managed to get myself into such a situation.
Dr. Eitan Yudilevich
Executive Director of the BIRD Foundation.
Originally published in the Hebrew newspaper – Globes
February 8, 2011
United States and Israel support foundation that facilitates business collaborations
It’s kind of like the song “Matchmaker” from Fiddler, only the BIRD Foundation is not in the business of romance, but rather the business of matchmaking services between Israeli and American companies in the realm of research and development.
The American Jewish World
May 25, 2011
AB103, a novel immunomodulator being developed for severe bacterial infections and sepsis. AB103 offers a unique approach in the treatment of infectious diseases by modulating but not inhibiting the host immune system.
Phase 1 was supported by a grant from the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation.
Atox Bio Inc.
May 12, 2011
An Israeli-United States effort is tops in technology alliances between the two countries, generating billions in sales from its beginnings.
With some 830 projects on the go, the Israel-US Binational Industrial Research and Development Foundation (BIRD) seems to be the most successful matchmaker in Israel’s business world.
Israel Ministry of Foreign Affairs
March 21, 2011
The right trousers
Robotics: An artificial exoskeleton, akin to a pair of robotic trousers, promises to bring hope and dignity to paraplegics by letting them walk
ReWalk consists of a set of plastic-covered aluminium struts, linked by actuator motors, that are strapped to the legs and waist, and a backpack. With these, and a pair of crutches for backup, a user can walk around.
The companies developing ReWalk have received a grant from The BIRD Foundation
The Economist | print edition
Mar 10, 2011
New drug for Gout: Krystexxa has been developed by Mountain View Pharmaceuticals, and Savient Pharmaceuticals, Inc.
The companies have received a grant from The BIRD Foundation
FDA Approves KRYSTEXXA(TM) (pegloticase) for the Treatment of Chronic Gout in Adult Patients
Special to The Washington Post
March 7, 2011
Magnetecs Corporation, a designer and manufacturer of robotic catheterization control systems for minimally invasive surgical procedures, today reported that the United States Patent Office has issued three patents to the Company related to its robotic Catheter Guidance Control and Imaging (CGCI) system for minimally invasive medical procedures
Magnetecs has received a grant of from the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation for a joint development project with Given Imaging Ltd, a world leading company from Israel in the field of gastroenterology, for a Magnetically Guided Capsule Endoscope.
Business Wire 2011
February 02, 2011
Collaboration goal, partially funded by BIRD Energy, is to develop and test a low-cost, nonintrusive, real-time energy monitoring platform
Dr. David Almagor
January 25, 2011
London. Two key biofuel deals laid down the carpet for the string of acquisitions, with Shell and Cargill co-investing $46.4m in US-based alternative fuel developer Virent. The Shell and Cosan tie-up raised its head again last week for securing European Union clearance.
Virent also secured a $900,000 government grant for Israeli and US government investment foundation BIRD to demonstrate the viability of drop-in biofuels.
January 16, 2011
BIRD Energy Grant Will Support Virent’s Conversion of HCL CleanTech’s Pine Tree Sugars Into Hydrocarbon Fuels and Products that can be Sustainable, Cost-effective, and Compatible with Existing Infrastructure
January 4, 2011